Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 4/2012

01.04.2012 | Original Article

Correlation of early-phase 18F-florbetapir (AV-45/Amyvid) PET images to FDG images: preliminary studies

verfasst von: Ing-Tsung Hsiao, Chin-Chang Huang, Chia-Ju Hsieh, Wen-Chun Hsu, Shiaw-Pyng Wey, Tzu-Chen Yen, Mei-Ping Kung, Kun-Ju Lin

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

18F-Florbetapir (AV-45/Amyvid) is a novel positron emission tomography (PET) tracer for imaging plaque pathology in Alzheimer’s disease (AD), while PET images of fluorodeoxyglucose (FDG) for cerebral glucose metabolism can provide complementary information to amyloid plaque images for diagnosis of AD. The goal of this preliminary study was to investigate the perfusion-like property of relative cerebral blood flow estimates (R1) and summed early-phase AV-45 images [perfusion AV-45 (pAV-45)] and optimize the early time frame for pAV-45.

Methods

Dynamic AV-45 PET scans (0–180 min) were performed in seven subjects. pAV-45, late-phase AV-45, and FDG images were spatially normalized to the Montreal Neurological Institute template aided by individual MRI images, and the corresponding standardized uptake value ratio (SUVR) was computed. The R1 images were derived from a simplified reference tissue model. Correlations between regional and voxelwise R1 and the corresponding FDG images were calculated. An optimization of time frames of pAV-45 was conducted in terms of correlation to FDG images. The optimal early time frame was validated in a separate cohort.

Results

The regional distribution in the R1 images correlated well (R = 0.91) to that of the FDG within subjects. Consistently high correlation was noted across a long range of time frames. The maximal correlation of pAV-45 to FDG SUVR of R = 0.95 was observed at the time frame of 1–6 min, while the peak correlation of R = 0.99 happened at 0–2 min between pAV-45 and R1. A similar result was achieved in the validation cohort.

Conclusion

Preliminary results showed that the distribution patterns of R1 and pAV-45 images are highly correlated with normalized FDG images, and the initial 5-min early time frame of 1–6 min is potentially useful in providing complementary FDG-like information to the amyloid plaque density by late-phase AV-45 images.
Literatur
1.
Zurück zum Zitat Ikonomovic M, Klunk W, Abrahamson E, Mathis C, Price J, Tsopelas N, et al. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer’s disease. Brain 2008;131:1630–45.PubMedCrossRef Ikonomovic M, Klunk W, Abrahamson E, Mathis C, Price J, Tsopelas N, et al. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer’s disease. Brain 2008;131:1630–45.PubMedCrossRef
2.
Zurück zum Zitat Kemppainen NM, Aalto S, Wilson IA, Någren K, Helin S, Brück A, et al. Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease. Neurology 2006;67:1575–80.PubMedCrossRef Kemppainen NM, Aalto S, Wilson IA, Någren K, Helin S, Brück A, et al. Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease. Neurology 2006;67:1575–80.PubMedCrossRef
3.
Zurück zum Zitat Fripp J, Bourgeat P, Acosta O, Raniga P, Modat M, Pike K, et al. Appearance modeling of 11C PiB PET images: characterizing amyloid deposition in Alzheimer’s disease, mild cognitive impairment and healthy aging. Neuroimage 2008;43:430–9.PubMedCrossRef Fripp J, Bourgeat P, Acosta O, Raniga P, Modat M, Pike K, et al. Appearance modeling of 11C PiB PET images: characterizing amyloid deposition in Alzheimer’s disease, mild cognitive impairment and healthy aging. Neuroimage 2008;43:430–9.PubMedCrossRef
4.
Zurück zum Zitat Edison P, Archer HA, Hinz R, Hammers A, Pavese N, Tai YF, et al. Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study. Neurology 2007;68:501–8.PubMedCrossRef Edison P, Archer HA, Hinz R, Hammers A, Pavese N, Tai YF, et al. Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study. Neurology 2007;68:501–8.PubMedCrossRef
5.
Zurück zum Zitat Verhoeff N, Wilson A, Takeshita S, Trop L, Hussey D, Singh K, et al. In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET. Am J Geriatr Psychiatry 2004;12:584–95.PubMed Verhoeff N, Wilson A, Takeshita S, Trop L, Hussey D, Singh K, et al. In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET. Am J Geriatr Psychiatry 2004;12:584–95.PubMed
6.
Zurück zum Zitat Choi SR, Golding G, Zhuang Z, Zhang W, Lim N, Hefti F, et al. Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain. J Nucl Med 2009;50:1887–94.PubMedCrossRef Choi SR, Golding G, Zhuang Z, Zhang W, Lim N, Hefti F, et al. Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain. J Nucl Med 2009;50:1887–94.PubMedCrossRef
7.
Zurück zum Zitat Lowe VJ, Kemp BJ, Jack Jr CR, Senjem M, Weigand S, Shiung M, et al. Comparison of 18F-FDG and PiB PET in cognitive impairment. J Nucl Med 2009;50:878–86.PubMedCrossRef Lowe VJ, Kemp BJ, Jack Jr CR, Senjem M, Weigand S, Shiung M, et al. Comparison of 18F-FDG and PiB PET in cognitive impairment. J Nucl Med 2009;50:878–86.PubMedCrossRef
8.
Zurück zum Zitat Zhou Y, Resnick S, Ye W, Fan H, Holt D, Klunk W, et al. Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer’s disease. Neuroimage 2007;36:298–312.PubMedCrossRef Zhou Y, Resnick S, Ye W, Fan H, Holt D, Klunk W, et al. Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer’s disease. Neuroimage 2007;36:298–312.PubMedCrossRef
9.
Zurück zum Zitat Ng S, Villemagne V, Berlangieri S, Lee S, Cherk M, Gong S, et al. Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer’s disease. J Nucl Med 2007;48:547–52.PubMedCrossRef Ng S, Villemagne V, Berlangieri S, Lee S, Cherk M, Gong S, et al. Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer’s disease. J Nucl Med 2007;48:547–52.PubMedCrossRef
10.
Zurück zum Zitat Mosconi L, Tsui WH, Herholz K, Pupi A, Drzezga A, Lucignani G, et al. Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer’s disease, and other dementias. J Nucl Med 2008;49:390–8.PubMedCrossRef Mosconi L, Tsui WH, Herholz K, Pupi A, Drzezga A, Lucignani G, et al. Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer’s disease, and other dementias. J Nucl Med 2008;49:390–8.PubMedCrossRef
11.
Zurück zum Zitat Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM. Longitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimer’s disease treatment studies. Am J Psychiatry 2002;159:738–45.PubMedCrossRef Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM. Longitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimer’s disease treatment studies. Am J Psychiatry 2002;159:738–45.PubMedCrossRef
12.
Zurück zum Zitat Treyer V, Streffer J, Wyss MT, Bettio A, Ametamey SM, Fischer U, et al. Evaluation of the metabotropic glutamate receptor subtype 5 using PET and 11C-ABP688: assessment of methods. J Nucl Med 2007;48:1207–15.PubMedCrossRef Treyer V, Streffer J, Wyss MT, Bettio A, Ametamey SM, Fischer U, et al. Evaluation of the metabotropic glutamate receptor subtype 5 using PET and 11C-ABP688: assessment of methods. J Nucl Med 2007;48:1207–15.PubMedCrossRef
13.
Zurück zum Zitat Koeppe RA, Gilman S, Joshi A, Liu S, Little R, Junck L, et al. 11C-DTBZ and 18F-FDG PET measures in differentiating dementias. J Nucl Med 2005;46:936–44.PubMed Koeppe RA, Gilman S, Joshi A, Liu S, Little R, Junck L, et al. 11C-DTBZ and 18F-FDG PET measures in differentiating dementias. J Nucl Med 2005;46:936–44.PubMed
14.
Zurück zum Zitat Murase K, Tanada S, Fujita H, Sakaki S, Hamamoto K. Kinetic behavior of technetium-99m-HMPAO in the human brain and quantification of cerebral blood flow using dynamic SPECT. J Nucl Med 1992;33:135–43.PubMed Murase K, Tanada S, Fujita H, Sakaki S, Hamamoto K. Kinetic behavior of technetium-99m-HMPAO in the human brain and quantification of cerebral blood flow using dynamic SPECT. J Nucl Med 1992;33:135–43.PubMed
15.
Zurück zum Zitat Gur RC, Ragland JD, Reivich M, Greenberg JH, Alavi A, Gur RE. Regional differences in the coupling between resting cerebral blood flow and metabolism may indicate action preparedness as a default state. Cereb Cortex 2009;19:375–82.PubMedCrossRef Gur RC, Ragland JD, Reivich M, Greenberg JH, Alavi A, Gur RE. Regional differences in the coupling between resting cerebral blood flow and metabolism may indicate action preparedness as a default state. Cereb Cortex 2009;19:375–82.PubMedCrossRef
16.
Zurück zum Zitat Wong CO, Thie J, Gaskill M, Ponto R, Hill J, Tian H, et al. A statistical investigation of normal regional intra-subject heterogeneity of brain metabolism and perfusion by F-18 FDG and O-15 H2O PET imaging. BMC Nucl Med 2006;6:4.PubMedCrossRef Wong CO, Thie J, Gaskill M, Ponto R, Hill J, Tian H, et al. A statistical investigation of normal regional intra-subject heterogeneity of brain metabolism and perfusion by F-18 FDG and O-15 H2O PET imaging. BMC Nucl Med 2006;6:4.PubMedCrossRef
17.
Zurück zum Zitat Meyer PT, Hellwig S, Amtage F, Rottenburger C, Sahm U, Reuland P, et al. Dual-biomarker imaging of regional cerebral amyloid load and neuronal activity in dementia with PET and 11C-labeled Pittsburgh compound B. J Nucl Med 2011;52:393–400.PubMedCrossRef Meyer PT, Hellwig S, Amtage F, Rottenburger C, Sahm U, Reuland P, et al. Dual-biomarker imaging of regional cerebral amyloid load and neuronal activity in dementia with PET and 11C-labeled Pittsburgh compound B. J Nucl Med 2011;52:393–400.PubMedCrossRef
18.
Zurück zum Zitat Rostomian AH, Madison C, Rabinovici GD, Jagust WJ. Early 11C-PIB frames and 18F-FDG PET measures are comparable: a study validated in a cohort of AD and FTLD patients. J Nucl Med 2011;52:173–9.PubMed Rostomian AH, Madison C, Rabinovici GD, Jagust WJ. Early 11C-PIB frames and 18F-FDG PET measures are comparable: a study validated in a cohort of AD and FTLD patients. J Nucl Med 2011;52:173–9.PubMed
19.
Zurück zum Zitat Yao CH, Lin KJ, Weng CC, Hsiao IT, Ting YS, Yen TC, et al. GMP-compliant automated synthesis of [(18)F] AV-45 (Florbetapir F 18) for imaging beta-amyloid plaques in human brain. Appl Radiat Isot 2010;68:2293–7.PubMedCrossRef Yao CH, Lin KJ, Weng CC, Hsiao IT, Ting YS, Yen TC, et al. GMP-compliant automated synthesis of [(18)F] AV-45 (Florbetapir F 18) for imaging beta-amyloid plaques in human brain. Appl Radiat Isot 2010;68:2293–7.PubMedCrossRef
20.
Zurück zum Zitat Joshi A, Koeppe RA, Fessler JA. Reducing between scanner differences in multi-center PET studies. Neuroimage 2009;46:154–9.PubMedCrossRef Joshi A, Koeppe RA, Fessler JA. Reducing between scanner differences in multi-center PET studies. Neuroimage 2009;46:154–9.PubMedCrossRef
21.
Zurück zum Zitat Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002;15:273–89.PubMedCrossRef Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002;15:273–89.PubMedCrossRef
22.
Zurück zum Zitat Wu Y, Carson RE. Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging. J Cereb Blood Flow Metab 2002;22:1440–52.PubMedCrossRef Wu Y, Carson RE. Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging. J Cereb Blood Flow Metab 2002;22:1440–52.PubMedCrossRef
23.
Zurück zum Zitat Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. Neuroimage 1996;4:153–8.PubMedCrossRef Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. Neuroimage 1996;4:153–8.PubMedCrossRef
24.
Zurück zum Zitat Lin KJ, Hsu WC, Hsiao IT, Wey SP, Jin LW, Skovronsky D, et al. Whole-body biodistribution and brain PET imaging with [18F]AV-45, a novel amyloid imaging agent–a pilot study. Nucl Med Biol 2010;37:497–508.PubMedCrossRef Lin KJ, Hsu WC, Hsiao IT, Wey SP, Jin LW, Skovronsky D, et al. Whole-body biodistribution and brain PET imaging with [18F]AV-45, a novel amyloid imaging agent–a pilot study. Nucl Med Biol 2010;37:497–508.PubMedCrossRef
25.
Zurück zum Zitat Clark CM, Schneider JA, Bedell BJ, Beach TG, Bilker WB, Mintun MA, et al. Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA 2011;305:275–83.PubMedCrossRef Clark CM, Schneider JA, Bedell BJ, Beach TG, Bilker WB, Mintun MA, et al. Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA 2011;305:275–83.PubMedCrossRef
26.
Zurück zum Zitat Nie NH, Bent DH, Hull CH. SPSS: Statistical Package for the Social Sciences. New York: McGraw-Hill; 1975. Nie NH, Bent DH, Hull CH. SPSS: Statistical Package for the Social Sciences. New York: McGraw-Hill; 1975.
27.
Zurück zum Zitat Reivich M. Blood flow metabolism couple in brain. Res Publ Assoc Res Nerv Ment Dis 1974;53:125–40.PubMed Reivich M. Blood flow metabolism couple in brain. Res Publ Assoc Res Nerv Ment Dis 1974;53:125–40.PubMed
28.
Zurück zum Zitat Powers WJ, Perlmutter JS, Videen TO, Herscovitch P, Griffeth LK, Royal HD, et al. Blinded clinical evaluation of positron emission tomography for diagnosis of probable Alzheimer’s disease. Neurology 1992;42:765–70.PubMed Powers WJ, Perlmutter JS, Videen TO, Herscovitch P, Griffeth LK, Royal HD, et al. Blinded clinical evaluation of positron emission tomography for diagnosis of probable Alzheimer’s disease. Neurology 1992;42:765–70.PubMed
29.
Zurück zum Zitat Blomquist G, Engler H, Nordberg A, Ringheim A, Wall A, Forsberg A, et al. Unidirectional influx and net accumulation of PIB. Open Neuroimag J 2008;2:114–25.PubMedCrossRef Blomquist G, Engler H, Nordberg A, Ringheim A, Wall A, Forsberg A, et al. Unidirectional influx and net accumulation of PIB. Open Neuroimag J 2008;2:114–25.PubMedCrossRef
Metadaten
Titel
Correlation of early-phase 18F-florbetapir (AV-45/Amyvid) PET images to FDG images: preliminary studies
verfasst von
Ing-Tsung Hsiao
Chin-Chang Huang
Chia-Ju Hsieh
Wen-Chun Hsu
Shiaw-Pyng Wey
Tzu-Chen Yen
Mei-Ping Kung
Kun-Ju Lin
Publikationsdatum
01.04.2012
Verlag
Springer-Verlag
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 4/2012
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-011-2051-2

Weitere Artikel der Ausgabe 4/2012

European Journal of Nuclear Medicine and Molecular Imaging 4/2012 Zur Ausgabe